Burden of SARS-CoV-2 infection and severe illness in South Africa (March 2020–August 2022): a synthesis of epidemiological data
Larisse Bolton, Stefano Tempia, Sibongile Walaza, Waasila Jassat, Kaiyuan Sun, Debbie Bradshaw, Rob Dorrington, Jackie Kleynhans, Neil Martenson, Anne von Gottberg, Nicole Wolter, Juliet R C Pulliam, Cheryl Cohen

TL;DR
This study estimates the impact of SARS-CoV-2 in South Africa from 2020 to 2022, showing high infection rates and severe illness, especially during the Delta wave.
Contribution
The study provides the first detailed national synthesis of SARS-CoV-2 disease burden and severity in South Africa across five waves.
Findings
The estimated cumulative infections reached 104.6 million by August 2022, with 0.38% severe non-fatal and 0.25-0.28% fatal cases.
The Delta wave had the highest burden of severe illness and death, while the Omicron wave showed a significant reduction in hospitalization-fatality ratios.
A large proportion of severe illness and deaths occurred outside hospitals, emphasizing the need for improved health-seeking and registration systems.
Abstract
Data on the burden of SARS-CoV-2 infections by age group and for different severity levels are lacking. We estimated the South African SARS-CoV-2 disease burden and severity, describing changes in the shape of the disease burden pyramid with successive waves. We estimated SARS-CoV-2 medically and non-medically attended illness stratified by severity (mild, severe non-fatal and fatal) during the initial five waves, spanning 1 March 2020 through 13 August 2022. We used individual-level national surveillance, healthcare utilisation and serosurvey data to estimate wave-specific hospitalisation-fatality (HFR) and infection-fatality ratios. We estimated wave-specific incidence rates per 100 000 population with 95% CIs derived from bootstrapping the individual-level data. On 13 August 2022, the estimated cumulative number of SARS-CoV-2 infections in South Africa was 104.6 million, of which…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · COVID-19 Clinical Research Studies · COVID-19 Impact on Reproduction
